Sandra Calvin

Insider Reports History

Location
San Diego, CA
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Calvin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Common Stock 49,080 $1,576,449 $32.12 03 Feb 2026 Direct
Travere Therapeutics, Inc. SVP, CHIEF ACCOUNTING OFFICER Employee stock option (right to buy) 20,160 31 Jan 2026 Direct

Insider Reports Filed by Sandra Calvin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TVTX Travere Therapeutics, Inc. 31 Jan 2026 3 -$139,176 4 SVP, CHIEF ACCOUNTING OFFICER 03 Feb 2026, 21:30
TVTX Travere Therapeutics, Inc. 24 Dec 2025 1 -$296,080 4 SVP, CHIEF ACCOUNTING OFFICER 29 Dec 2025, 20:59
TVTX Travere Therapeutics, Inc. 15 Dec 2025 1 -$104,760 4 SVP, CHIEF ACCOUNTING OFFICER 16 Dec 2025, 16:23
TVTX Travere Therapeutics, Inc. 04 Nov 2025 11 -$944,928 4 SVP, CHIEF ACCOUNTING OFFICER 06 Nov 2025, 16:05
TVTX Travere Therapeutics, Inc. 11 Feb 2025 13 -$607,900 4 SVP, CHIEF ACCOUNTING OFFICER 12 Feb 2025, 21:27
TVTX Travere Therapeutics, Inc. 31 Jan 2025 3 -$67,362 4 SVP, CHIEF ACCOUNTING OFFICER 04 Feb 2025, 20:30
TVTX Travere Therapeutics, Inc. 22 Jan 2025 1 -$17,520 4 SVP, CHIEF ACCOUNTING OFFICER 23 Jan 2025, 20:31
TVTX Travere Therapeutics, Inc. 26 Dec 2024 3 -$68,228 4 SVP, CHIEF ACCOUNTING OFFICER 27 Dec 2024, 19:47
TVTX Travere Therapeutics, Inc. 25 Nov 2024 3 -$31,208 4 SVP, CHIEF ACCOUNTING OFFICER 25 Nov 2024, 21:00
TVTX Travere Therapeutics, Inc. 31 Jan 2024 4 -$24,058 4 SVP, CHIEF ACCOUNTING OFFICER 02 Feb 2024, 16:05
TVTX Travere Therapeutics, Inc. 23 Jan 2024 1 -$8,252 4 SVP, CHIEF ACCOUNTING OFFICER 25 Jan 2024, 16:10
TVTX Travere Therapeutics, Inc. 10 May 2023 2 -$9,200 4 SVP, Chief Accounting Officer 12 May 2023, 16:06
TVTX Travere Therapeutics, Inc. 31 Jan 2023 4 -$44,419 4 SVP, Chief Accounting Officer 02 Feb 2023, 17:53
TVTX Travere Therapeutics, Inc. 24 Jan 2023 2 -$23,976 4 SVP, Chief Accounting Officer 26 Jan 2023, 15:05
TVTX Travere Therapeutics, Inc. 13 Sep 2022 1 -$9,772 4 SVP, Chief Accounting Officer 15 Sep 2022, 16:05
TVTX Travere Therapeutics, Inc. 10 May 2022 2 -$19,134 4 SVP, Chief Accounting Officer 12 May 2022, 20:44
TVTX Travere Therapeutics, Inc. 31 Jan 2022 3 -$21,152 4 VP, Corp Controller and CAO 02 Feb 2022, 15:22
TVTX Travere Therapeutics, Inc. 24 Jan 2022 1 -$22,955 4 VP, Corp Controller and CAO 26 Jan 2022, 15:38
TVTX Travere Therapeutics, Inc. 15 Sep 2021 0 $0 3 VP, Corp Controller and CAO 23 Sep 2021, 18:14